Hepatitis C in US Prisons: Prevalence & Barriers to Screening and Treating


Anne C. Spaulding, MD, MPH

Associate Professor, Department of Epidemiology, Emory University Rollins School of Public Health

Learning Objectives:

1. To be able to describe the portion of the US Hepatitis C epidemic borne by persons who go in and out of jails and prisons over the course of a year.
2. To explain why elimination of Hepatitis C in the US depends on treating correctional populations.
3. To describe the challenges prisons face in financing Hepatitis C cure for persons who are incarcerated.

A live webcast sponsored by:

Merck (Grant No. AAN170209041806), The N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667) and Clinical Directors Network, Inc. (CDN)


Thursday, January 25, 2018 from 12:30 PM to 2:00 PM EST

This activity is approved for up to 1.5 Prescribed credit(s) by the American Academy of Family Physicians (AAFP). Enduring CME Credits valid until January 25, 2019.

Recent Webcasts

Sex in the Time of COVID-19

Kenneth H. Mayer, M.D., Medical Research Director, Fenway Health, Co-Director, The Fenway Institute, Professor of Medicine, Harvard Medical School, Attending Physician, Infectious Disease...

Opioid Prescribing in the COVID-19 Era

Joanna L. Starrels, MD, MS, FACP, Associate Professor of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Division of General Internal Medicine
Hector R. Perez,...

Prescription Pain Medication Use in the Community

Linda B. Cottler, PhD, MPH, FACE, Associate Dean for Research, College of Public Health and Health Professions and Dean's Professor of Epidemiology at the University of Florida